MEC Basic Full List ViewBy pinki@katapult.biz / February 16, 2025 MEC Basic Speciality — Amyotrophic Lateral Sclerosis (ALS) Biomarkers Biosimilars Bladder Blood Bone Brain Breast Cancer Central Nervous System (CNS) Clinical Trials Colon Colorectal Diversity, Equity & Inclusion Featured Content Gastrointestinal Genitourinary Genomic Geriatric Gynecology Head and Neck Hematologic Hematologic Maglinencies Hematology Immunotherapy Interventional Radiology Kidney Leukemia Liquid Biopsy Liver Lung Lymphoma Malignant Malignencies Melanoma Myelodysplastic Syndrome Myeloma Neuroendocrine Novel Oral & Maxillofacial Surgery Oral Cancer Ovarian Pancreas Pancreatic Pharmacological Prostate Radiation Radiology Renal Sarcoma Skin Solid Tumor Supportive & Palliative Care Survivorship Telemedicine Thoracic Thrombosis Thymic Thyroid Urothelial Author / Speaker Title Type of Media — Video Document Audio Events — 2024 California Cancer Consortium Conference (CCC) 2024 MCM 2024 MCM 2024 MLS Cleveland 2024 MLS Nashville 2024 MLS New Orleans 2024 MLS Seattle 2024 New Orleans Summer Cancer Meeting (NOSCM) 2024 PRIMO 2024 SPS Puerto Rico 2024 SPS Seattle 2024 SPECTRUM 2024 Sylvester APP Oncology Symposium 2024 WCS 2024 MaTOS Lungs 2025 PRIMO Search Entries: « 1 … 29 30 31 32 33 … 74 » T-Cell NHL: Novel Approaches & Challenges Francine M. Foss, MD View PDF ADC in NSCLC: CEACAM5 and Teliso-V Julia Rotow, MD View PDF ADC in NSCLC: TROP2 and HER3 in NSCLC Hossein Borghaei, MD View PDF EGFRex20ins, METex14 and RET in NSCLC Mark Socinski, MD View PDF K-RAS and ERBB2 Mutation in NSCLC Yasir Elamin, MD View PDF Neoadjuvant and Adjuvant Immunotherapy in Early Stage Lung Cancer Karen Kelly, MD View PDF Novel Treatment for Unresectable Stage III NSCLC Edgardo S. Santos Castillero, MD, FACP View PDF Small Cell Lung Cancer: 1L and Beyond Anne Chiang, MD View PDF Identifying and Targeting Mechanisms of Resistance to 3rd Generation EGFR Inhibitors Ravi Salgia, MD View PDF ALK: Choosing 1L & Mechanism of Resistance Ibiayi Dagogo-Jack, MD View PDF Novel Advances in Mesothelioma Jorge E. Gomez, MD View PDF Pre-Operative and Metastatic Setting Biomarkers for Immunotherapy in Lung Cancer Fred Hirsch, MD View PDF ctDNA in Lung Cancer: Current State and Future Perspectives Bruna Pellini, MD View PDF Drug Development and New Targeted Agents for Breast Cancer: What Does the Future Hold? Mark Pegram, MD View PDF Sequencing Endocrine Therapy and Targeted Agents for the Treatment of Metastatic HR+/HER2- Breast Cancer Neelima Vidula, MD View PDF Optimal Treatment for Early Stage HER2 Positive Breast Cancer: Tailoring Treatment to Response Virginia Borges, MD View PDF Immunotherapy for Breast Cancer: Current and Future Directions Heather McArthur, MD View PDF Changing Delivery of Chemotherapy for Breast Cancer: The Broad Impact of Antibody Drug Conjugates Hope Rugo, MD, FASCO View PDF Survivorship in the Modern Era of Cancer Care: Goals, Measures, and Outcomes Adrienne M. Vazquez Guerra, MSN, ACNP-BC, AOCN View PDF Management of Osteonecrosis of Jaw and Other Complications from Bisphosphonate and/or RANK Ligand Inhibitors Robert E. Marx, DDS, FACS View PDF Telemedicine in Oncology Jack West, MD View PDF Medical Marijuana: Who, When & How? Dov Pickholtz, DO View PDF Melanoma: What is after immunotherapy? More immunomodulation? Sanjiv Agarwala, MD View PDF Toxicities in Immunotherapy Mayra A. Lima, ARNP, MSN, FNP-C View PDF Immunotherapy and Other Systemic Therapy in Gynecologic Malignancies Gerardo Colon-Otero, MD View PDF
